Research Article

# Partner Selection in a Virtual Enterprise: A Group Multiattribute Decision Model with Weighted Possibilistic Mean Values

## Table 1

The decision matrix with triangular fuzzy numbers and weights of six attributes for each decision maker.
 Decision maker Candidate and weight Cost Past performance Relationship closeness Completion probability Time Quality (9, 11, 12) (86, 89, 91) (82, 83, 84) (0.89, 0.90, 0.92) (21, 23, 25) (0.95, 0.96, 0.97) (10, 12, 14) (87, 90, 93) (84, 85, 86) (0.88, 0.91, 0.92) (23, 24, 25) (0.96, 0.97, 0.98) (12, 13, 15) (90, 93, 94) (87, 88, 89) (0.92, 0.93, 0.94) (22, 23, 24) (0.96, 0.97, 0.98) (14, 15, 16) (92, 94, 95) (91, 92, 94) (0.95, 0.97, 0.98) (18, 19, 21) (0.97, 0.98, 0.99) Weight 0.10 0.25 0.15 0.20 0.14 0.16 (9, 11, 13) (88, 90, 92) (79, 80, 82) (0.90, 0.91, 0.92) (23, 24, 25) (0.96, 0.97, 0.98) (11, 12, 13) (87, 89, 91) (83, 84, 85) (0.89, 0.90, 0.91) (21, 22, 23) (0.95, 0.96, 0.97) (12, 13, 14) (90, 91, 92) (86, 87, 88) (0.92, 0.93, 0.94) (22, 23, 24) (0.96, 0.97, 0.98) (13, 14, 15) (92, 93, 94) (87, 89, 90) (0.91, 0.92, 0.93) (18, 19, 21) (0.96, 0.97, 0.99) Weight 0.11 0.21 0.16 0.21 0.15 0.16 (11, 12, 13) (88, 89, 90) (75, 76, 78) (0.91, 0.92, 0.94) (21, 22, 23) (0.96, 0.97, 0.98) (12, 13, 14) (87, 89, 90) (76, 78, 80) (0.90, 0.91, 0.92) (20, 21, 23) (0.95, 0.97, 0.98) (13, 14, 15) (89, 90, 91) (82, 84, 85) (0.94, 0.95, 0.96) (20, 21, 22) (0.96, 0.98, 0.99) (14, 15, 17) (88, 90, 92) (84, 85, 86) (0.93, 0.94, 0.95) (18, 20, 21) (0.97, 0.98, 0.99) Weight 0.09 0.26 0.14 0.19 0.17 0.15 (12, 13, 14) (87, 89, 90) (76, 77, 78) (0.88, 0.90, 0.91) (21, 22, 23) (0.94, 0.95, 0.96) (13, 14, 15) (88, 89, 91) (81, 82, 83) (0.89, 0.90, 0.92) (19, 21, 23) (0.93, 0.94, 0.95) (16, 17, 18) (87, 88, 89) (84, 85, 86) (0.95, 0.96, 0.97) (20, 21, 22) (0.94, 0.95, 0.96) (15, 16, 18) (89, 90, 91) (86, 87, 88) (0.94, 0.95, 0.96) (19, 21, 22) (0.95, 0.96, 0.97) Weight 0.12 0.24 0.16 0.17 0.15 0.16

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.